Trivascular Technologies (TRIV) Annual Balance Sheets

Annual · GAAP · USD millions
Access TRIV quarterly Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Trivascular Technologies.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2014)
Assets
Cash & cash equivalent32.90
Available-for-sale Securities, Current MA46.08
Cash & Short-term Investments78.00
Accounts receivable6.57
Inventories8.57
Prepaid Expense And Other Assets Current2.93
Total Current Assets97.05
Equipment/Property/Plant Net1.25
Goodwill net8.26
Intangible Assets1.18
Other Assets, Noncurrent0.80
Total Assets108.53
Liabilities
Accounts Payable, Current AC1.86
Total Current Liabilities10.33
Long-term debt55.00
Total Long-term Debt55.00
Other liabilities, Noncurrent3.63
Accrued Liabilities And Other Liabilities Current8.47
Total Liabilities68.96
Stockholders' Equity
Common Stock Value0.20
Additional Paid In Capital Common Stock335.45
Retained Earnings / Accumulated Deficit-295.89
Other Equity-0.18
Common Stockholder's Equity39.57
Total Stockholder's Equity39.57
Liabilities & Stockholder's Equity108.53
4 historic quarters locked

Sign in to unlock the full Trivascular Technologies balance sheet history.

About TRIV Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License